A Challenging Case of Weil's Disease
DOI:
https://doi.org/10.60591/crspmi.49Keywords:
Acute Kidney Injury, Leptopirosis, Weil DiseaseAbstract
Leptospirosis is the most widely disseminated zoonosis worldwide. It represents a re-emerging disease with a high distribution in Portugal, being a nationally notifiable disease. Due to the low specificity of the initial symptoms and signs, it is often confused with other diseases, however it can be extremely severe. The authors will present a challenging case of leptospirosis and the complexity of the approach and treatment.
Downloads
References
Instituto de Higiene e Medicina Tropical. Leptospirose. 2020 [consultado Jan 2022] Disponível em: http://ihmt.unl.pt/glossay/leptospirose/.
Evangelista KV, Coburn J. Leptospira as an emerging pathogen: a review of its biology, pathogenesis and host immune responses. Future Microbiol. 2010;5:1413-25. doi: 10.2217/fmb.10.102.
Vieira ML, Gama-Simões MJ, Collares-Pereira M. Human leptospirosis in Portugal: A retrospective study of eighteen years. Int J Infect Dis. 2006;10:378-86. doi: 10.1016/j.ijid.2005.07.006.
Kobayashi Y. Clinical observation and treatment of leptospirosis. J Infect Chemother. 2001;7:59-68. doi: 10.1007/s101560100011.
Leptospirosis, section 9, chapter 184. In: Loscalzo J, Kasper DL, Jameson JL, Fauci AS, Longo DL, Hauser SL, editors. Harrison’s Principles of Internal Medicine. 21th ed.New York City: Mc-Graw Hill Professional; 2022. p.5334-52.
Araujo ER, Seguro AC, Spichler A, Magaldi AJ, Volpini RA, De Brito T. Acute kidney injury in human leptospirosis: an immunohistochemical study with pathophysiological correlation. Virchows Arch. 2010;456:367-75. doi: 10.1007/s00428-010-0894-8.
Russell CD, Jones ME, O'Shea DT, Simpson KJ, Mitchell A, Laurenson IF. Challenges in the diagnosis of leptospirosis outwith endemic settings: a Scottish single centre experience. J R Coll Physicians Edinb. 2018;48:9-15. doi: 10.4997/JRCPE.2018.102.
Le Turnier P, Epelboin L. Mise au point sur la leptospirose. Rev Med Interne. 2019;40:306-12.
Rajapakse S. Leptospirosis: clinical aspects. Clin Med. 2022;22:14-7. doi: 10.7861/clinmed.2021-0784.
Suputtamongkol Y, Pongtavornpinyo W, Lubell Y, Suttinont C, Hoontrakul S, Phimda K. et al. Strategies for Diagnosis and Treatment of Suspected Leptospirosis: A cost-benefit analysis. PloS Negl Trop Dis. 2010;4:e610.
Prowle JR, Echeverri JE, Ligabo EV, Ronco C, Bellomo R. Fluid balance and acute kidney injury. Nat Rev Nephrol. 2010;6:107-15. doi: 10.1038/nrneph.2009.213.
Andrade L, Cleto S, Seguro AC. Door-to-dialysis time and daily hemodialysis in patients with leptospirosis: impact on mortality. Clin J Am Soc Nephrol. 2007;2:739-44. doi: 10.2215/CJN.00680207.
Mukadi P, Tabei K, Edwards T, Brett-Major DM, Smith C, Kitashoji E et al. Antibiotics for treatment of leptospirosis. Cochrane Database Syst Rev. 2022: 11; CD014959. doi: 10.1002/14651858.CD0149
Daher EF, Silva GB, Abreu KL, Mota RM, Batista DV, Rocha NA, et al. Leptospirosis-associated acute kidney injury: penicillin at the late stage is still controversial. J Clin Pharm Ther. 2012;37:420-5. doi: 10.1111/j.1365-2710.2011.01312.x.
Sehgal SC, Sugunan AP, Murhekar MV, Sharma S, Vijayachari P. Randomized controlled trial of doxycycline prophylaxis against leptospirosis in an endemic area. Int J Antimicrob Agents. 2000;13:249-55. doi: 10.1016/s0924-8579(99)00134-x.
